Anti‐GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric Diseases
- 9 October 2016
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 68 (11) , 2708-2716
Abstract
Objective: To investigate the potential role of circulating autoantibodies specific to neuronal cell surface antigens in the pathophysiology of neuropsychiatric disorders.Methods: Two different kinds of immunoscreening approaches were used to identify autoantigens associated with neuropsychiatric disorders in the serum of patients with schizophrenia. The presence of autoantibodies specific to the identified autoantigens was then tested in patients with various psychiatric disorders and in patients with systemic lupus erythematosus (SLE) and concomitant neuropsychiatric manifestations. Furthermore, the potential pathogenic role of these autoantibodies was assessed both in vitro and in vivo.Results: GAPDH was identified as a novel autoantigen associated with neuropsychiatric disorders. Serum anti‐GAPDH IgG was detected in the serum of 51% of patients with schizophrenia and 50% of patients with major depression. Moreover, SLE patients with comorbid psychiatric manifestations presented significantly higher serum levels of anti‐GAPDH antibodies than did SLE patients without psychiatric manifestations (P = 0.004 by chi‐square test). Of note, a significant positive correlation (R = 0.48, P = 0.0049, by Spearman's rank correlation test) was found between the levels of serum anti‐GAPDH antibodies and cognitive dysfunction in patients with SLE. In vitro analysis of the effects of purified human anti‐GAPDH autoantibodies on SH‐SY5Y cells showed an immediate neurite retraction. Finally, in vivo administration of anti‐GAPDH autoantibodies in the right cerebral ventricle of C57BL/6J mice resulted in specific behavioral changes associated with a detrimental cognitive and emotional profile.Conclusion: Overall, these data suggest that anti‐GAPDH autoantibodies play a role in the pathogenesis of neuropsychiatric disorders, thus representing a potentially promising tool for the screening of individual vulnerability to these disabling conditions.Keywords
Funding Information
- the Ministry of Health
This publication has 45 references indexed in Scilit:
- Autoantibodies and the Immune Hypothesis in Psychotic Brain Diseases: Challenges and PerspectivesJournal of Immunology Research, 2013
- Direct interaction between GluR2 and GAPDH regulates AMPAR-mediated excitotoxicityMolecular Brain, 2012
- Interaction Network of the 14-3-3 Protein in the Ancient Protozoan Parasite Giardia duodenalisJournal of Proteome Research, 2012
- The novel object recognition memory: neurobiology, test procedure, and its modificationsCognitive Processing, 2011
- The Emerging Link Between Autoimmune Disorders and Neuropsychiatric DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2011
- Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studiesEuropean Journal of Neuroscience, 2010
- Anti-α-Internexin Autoantibody from Neuropsychiatric Lupus Induce Cognitive Damage via Inhibiting Axonal Elongation and Promote Neuron ApoptosisPLOS ONE, 2010
- Extracellular GAPDH binds to L1 and enhances neurite outgrowthMolecular and Cellular Neuroscience, 2009
- Human lupus autoantibodies against NMDA receptors mediate cognitive impairmentProceedings of the National Academy of Sciences, 2006
- The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer’s disease-like tau phosphorylationBiochemical and Biophysical Research Communications, 2004